Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code QQX: Respiratory Specimen Nucleic Acid Sars-Cov-2 Test. Open this device type's page
11 decisions
product code QQX. Showing 1 to 11, newest first. PMA results are original approvals and panel-track supplements.
- Aptima SARS-CoV-2 Assay510(k)
K243396 · Decided Feb 13, 2025 · 105 days after receipt
Device type: Respiratory Specimen Nucleic Acid Sars-Cov-2 Test (QQX) · Laboratory Medicine & Pathology
K240867 · Decided Feb 11, 2025 · 319 days after receipt
Device type: Respiratory Specimen Nucleic Acid Sars-Cov-2 Test (QQX) · Laboratory Medicine & Pathology
K242109 · Decided Jan 15, 2025 · 180 days after receipt
Device type: Respiratory Specimen Nucleic Acid Sars-Cov-2 Test (QQX) · Laboratory Medicine & Pathology
8 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.